Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 0.65 | 13.58 |
| PEG Ratio (TTM) | -0.04 | -2.34 |
| P/S Ratio (TTM) | 0.07 | 2.76 |
| P/B Ratio (TTM) | 0.02 | 2.63 |
| P/FCF Ratio (TTM) | -0.30 | 7.32 |
| Price to 5YR AVG Earnings Ratio | N/A | 11.77 |
| Price to 5YR AVG FCF Ratio | N/A | 3.51 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.08% | 5.29% |
| ROE (TTM) | 2.62% | 19.21% |
| Net Profit Margin (TTM) | 8.68% | -127.31% |
| ROIC 5YR AVG | N/A | 27.34% |
Growth (47%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 9,135.91% | 8.12% | N/A |
| Revenue | 11.34% | 685.40% | N/A |
| Net Income | -65.91% | -21.51% | N/A |
| Cash Flow | 5.67% | 453.17% | N/A |
Health (51%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 7.86 | 2.06 |
| Quick Ratio (TTM) | 7.86 | 1.64 |
| D/E Ratio (TTM) | 0.01 | 0.41 |
| Interest Coverage (TTM) | -4.71 | 3.79 |
| Piotroski F-Score | 4 | 7 |
| Altman Z-Score | 0.70 | 3.49 |
| LTL to 5YR AVG FCF | N/A | -3.58 |
| Shares Outstanding Growth 5YR AVG | N/A | 18.22% |